Amgen ROE - Return on Equity 2010-2025 | AMGN

Amgen return on equity for the quarter ending March 31, 2025 was 92.94.

  • Amgen average return on equity for 2024 was 61.17, a 59.66% increase from 2023.
  • Amgen average return on equity for 2023 was 151.62, a 11.47% decline from 2022.
  • Amgen average return on equity for 2022 was 171.26, a 156.53% decline from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.

Amgen ROE - Return on Equity 2010-2025 | AMGN

  • Amgen average return on equity for 2024 was 61.17, a 59.66% increase from 2023.
  • Amgen average return on equity for 2023 was 151.62, a 11.47% decline from 2022.
  • Amgen average return on equity for 2022 was 171.26, a 156.53% decline from 2021.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.